GLP-1 drugs, including Wegovy, Zepbound, and Foundayo, help patients lose weight by mimicking a hormone that makes the body ...

Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks on September 15 ...

GSK will acquire a trispecific T cell engager for multiple myeloma from Chimagen Biosciences in a deal worth up to $750 ...

Nigeria’s corporate exodus story is now familiar, with ride-hailing app Uber’s September 2nd exit, after twelve years in the market, the latest. Recently, hypermarket giant Shoprite has wound down its ...

GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at ...

GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is ...

GSK trades at GBX1,860.50 today, up 0.4%. Key technicals highlight sideways movement and volatility in the short term.

GSK said on Tuesday it had agreed a deal worth up to $750 million ​to buy a trispecific T cell-engager (TCE), a drug ‌designed to help T-cells target cancer, from China-based biotechnology firm ...

Berenberg analyst Kerry Holford upgraded GlaxoSmithKline (NYSE: GSK) from Hold to Buy with a price target of $60.00 (from $54.00). For an analyst ratings summary and ratings ...

Berenberg analyst Kerry Holford upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Hold to Buy with a price target of GBP22.00 (from GBP20.00).The analyst comments: Following the spin-off ...

Shareholders approved appointment of Karine Natland as non-executive director with 99.71% vote share. Bhushan Akshikar re-appointed as managing director with 99.71% shareholder approval. Promoter ...

Vaccine production in Germany's Dresden is set to end after 115 years, with pharmaceutical group GlaxoSmithKline (GSK) ...